Wolverine Trading
MDCO

Wolverine Trading’s Medicines Co MDCO Stock Holding History

Wolverine Trading’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,660
Closed -$4.3M – 5701
2019
Q4 		$4.3M Buy
50,660
+31,192
+160% +$2.08M 0.01% 1218
2019
Q3 		$938K Buy
+19,468
New +$777K ﹤0.01% 2048
2018
Q4 		– Sell
-29,181
Closed -$679K – 5776
2018
Q3 		$873K Buy
+29,181
New +$1.1M ﹤0.01% 2511
2017
Q4 		– Sell
-12,552
Closed -$387K – 5805
2017
Q3 		$465K Buy
12,552
+3,377
+37% +$124K ﹤0.01% 2692
2017
Q2 		$356K Sell
9,175
-153
-2% -$6.81K ﹤0.01% 2795
2017
Q1 		$458K Buy
9,328
+483
+5% +$22K ﹤0.01% 2497
2016
Q4 		$300K Sell
8,845
-2,686
-23% -$95.3K ﹤0.01% 3266
2016
Q3 		$439K Sell
11,531
-1,533
-12% -$57.8K ﹤0.01% 2736
2016
Q2 		$442K Buy
+13,064
New +$461K ﹤0.01% 2342

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wolverine Trading's MDCO Position: Q1 2020 in Review

Wolverine Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 50,660 shares — an estimated $4.3M sold.

Wolverine Trading first reported a position in MDCO in Q2 2016 and held it in 9 quarters. The position peaked at $4.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Wolverine Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 50,660 Medicines Co shares in Q1 2020, an estimated $4.3M.
  • Wolverine Trading first reported a position in Medicines Co in Q2 2016 and held it in 9 quarters.
  • Wolverine Trading's Medicines Co position peaked at $4.3M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.